NCT06910657 2026-03-02IDOV-Immune for Advanced Solid TumorsViroMissile, Inc.Phase 1 Recruiting78 enrolled
NCT03746431 2026-01-07A Phase 1 Study of [225Ac]-FPI-1434 InjectionFusion Pharmaceuticals Inc.Phase 1 Terminated78 enrolled
NCT06943521 2025-12-11A Study of MT-4561 in Patients With Various Advanced Solid TumorsTanabe Pharma America, Inc.Phase 1/2 Recruiting27 enrolled
NCT07181720 2025-10-02CD70-Targeted CAR-T Therapy in CD70-Positive Advanced Solid TumorsChongqing Precision Biotech Co., LtdPhase 1 Recruiting90 enrolled
NCT04731467 2024-12-27A Study of CM24 in Combination with Nivolumab in Adults with Advanced Solid TumorsPurple Biotech Ltd.Phase 1/2 Completed79 enrolled
NCT05500508 2024-12-24Oral AMXT 1501 Dicaprate in Combination With IV DFMOAminex Therapeutics, Inc.Phase 1/2 Terminated15 enrolled
NCT04985357 2024-11-25Defining the Clinical Potential of Mass Response As a Biomarker for Patient Tumor Sensitivity to DrugsTravera IncWithdrawn